Flying without a net in MDS

Blood. 2013 Oct 24;122(17):2925-6. doi: 10.1182/blood-2013-09-525444.

Abstract

In this issue of Blood, Malcovati et al discuss the findings of an expert panel of the European LeukemiaNet (ELN) and their recommendations for treating myelodysplastic syndromes (MDS).

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Myelodysplastic Syndromes / diagnosis*
  • Myelodysplastic Syndromes / therapy*

Substances

  • Antineoplastic Agents